Medpace Holdings, Inc. to Report First Quarter 2022 Financial Results on April 25, 2022

Rhea-AI Summary

Medpace Holdings, Inc. (NASDAQ: MEDP) will release its first quarter 2022 financial results on April 25, 2022, after market close. A conference call is scheduled for April 26, 2022, at 9:00 a.m. ET to discuss the results. Interested participants can join by dialing 800-219-7113 (domestic) or 574-990-1030 (international) with passcode 3191816, or access the call via webcast on Medpace’s website. The call will be available for replay until May 3, 2022.

CINCINNATI--(BUSINESS WIRE)-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2022 financial results after the market close on Monday, April 25, 2022. The Company will host a conference call the following morning, Tuesday, April 26, 2022, at 9:00 a.m. ET to discuss these results.

To participate in the conference call, dial 800-219-7113 (domestic) or 574-990-1030 (international) using the passcode 3191816.

To access the conference call via webcast, visit the “Investors” section of Medpace’s website at investor.medpace.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

A supplemental slide presentation will also be available at the “Investors” section of Medpace’s website prior to the start of the call.

A recording of the call will be available until Tuesday, May 3, 2022. To hear this recording, dial 855-859-2056 (domestic) or 404-537-3406 (international) using the passcode 3191816.

About Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,500 people across 41 countries as of December 31, 2021.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220317005907/en/

Investor Contact:

Lauren Morris

513.579.9911 x11994

l.morris@medpace.com

Media Contact:

Julie Hopkins

513.579.9911 x12627

j.hopkins@medpace.com

Source: Medpace Holdings, Inc.

FAQ

When will Medpace Holdings report its Q1 2022 financial results?

Medpace Holdings will report its Q1 2022 financial results on April 25, 2022.

What time is the Medpace Q1 2022 earnings conference call?

The Medpace Q1 2022 earnings conference call will be held on April 26, 2022, at 9:00 a.m. ET.

How can I participate in the Medpace earnings call?

To participate in the Medpace earnings call, dial 800-219-7113 (domestic) or 574-990-1030 (international) using passcode 3191816.

Where can I find the Medpace earnings call webcast?

The Medpace earnings call webcast can be accessed on the 'Investors' section of Medpace’s website.

Until when will the Medpace Q1 2022 earnings call recording be available?

The Medpace Q1 2022 earnings call recording will be available until May 3, 2022.